Holen Sie sich die Stockscreener-App
8.31
3.62%
0.29
Handel nachbörslich:
8.39
0.08
+0.96%
Schlusskurs vom Vortag:
$8.02
Offen:
$8.15
24-Stunden-Volumen:
2.64M
Relative Volume:
1.64
Marktkapitalisierung:
$723.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-168.09M
KGV:
-3.8295
EPS:
-2.17
Netto-Cashflow:
$-138.01M
1W Leistung:
+6.13%
1M Leistung:
-9.77%
6M Leistung:
+28.04%
1J Leistung:
+0.36%
1-Tages-Spanne:
$8.065
$8.40
1-Wochen-Bereich:
$7.50
$8.40
52-Wochen-Spanne:
$5.41
$12.49
Kura Oncology Inc Stock (KURA) Company Profile
Firmenname
Kura Oncology Inc
Sektor
Branche
Telefon
(858) 500-8800
Adresse
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA
Compare KURA vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KURA
Kura Oncology Inc
|
8.31 | 697.88M | 0 | -168.09M | -138.01M | -2.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
491.47 | 117.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
803.17 | 82.85B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
821.96 | 51.58B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
314.40 | 40.75B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.07 | 38.33B | 4.98B | 69.60M | 525.67M | 0.5198 |
Kura Oncology Inc Stock (KURA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-04 | Eingeleitet | Guggenheim | Neutral |
| 2025-02-06 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-14 | Herabstufung | Stifel | Buy → Hold |
| 2023-12-22 | Eingeleitet | Mizuho | Buy |
| 2023-08-11 | Eingeleitet | BofA Securities | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Perform |
| 2023-05-17 | Eingeleitet | BTIG Research | Buy |
| 2023-01-31 | Eingeleitet | Stifel | Buy |
| 2022-07-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-02-15 | Eingeleitet | Jefferies | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-12-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-12-03 | Eingeleitet | Stifel | Buy |
| 2020-11-05 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Credit Suisse | Outperform |
| 2020-05-05 | Eingeleitet | Barclays | Overweight |
| 2019-07-18 | Eingeleitet | Deutsche Bank | Buy |
| 2018-11-09 | Eingeleitet | Piper Jaffray | Overweight |
| 2018-08-01 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-10-13 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-01-22 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-30 | Eingeleitet | Oppenheimer | Outperform |
| 2015-12-16 | Eingeleitet | Citigroup | Buy |
Alle ansehen
Kura Oncology Inc Aktie (KURA) Neueste Nachrichten
What is Kura Oncology Inc. s P E ratio telling us2025 Price Targets & Accurate Entry and Exit Point Alerts - mfd.ru
Kura Oncology (NASDAQ:KURA) Share Price Crosses Below 50-Day Moving AverageHere's Why - MarketBeat
Kura Oncology, Inc. (KURA) Stock Report: Eyeing a 304% Upside with Groundbreaking Cancer Therapies - DirectorsTalk Interviews
Will Kura Oncology Inc. stock benefit from upcoming earnings reports2025 Key Highlights & Scalable Portfolio Growth Methods - mfd.ru
IPO Launch: Is Kura Oncology Inc a strong candidate for buy and holdJuly 2025 Retail & Free Verified High Yield Trade Plans - baoquankhu1.vn
Is Kura Oncology Inc. vulnerable to short sellersPortfolio Return Report & Daily Price Action Insights - mfd.ru
The Truth About Kura Oncology Inc: Is This Sleeper Cancer Stock About To Explode? - AD HOC NEWS
Kura Oncology (KURA) Issues Stock Options to New Employees - GuruFocus
Kura Oncology Grants Inducement Stock Options to New Employees as Part of 2023 Inducement Option Plan - Quiver Quantitative
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Need To Know: The Consensus Just Cut Its Kura Oncology, Inc. (NASDAQ:KURA) Estimates For 2026 - simplywall.st
Why (KURA) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Analyst flags Kura Oncology, Inc. (KURA) for 2026 milestones and pipeline expansion - MSN
Analyst Flags Kura Oncology, Inc. (KURA) for 2026 Milestones and Pipeline Expansion - Yahoo Finance
Citizens reiterates Market Outperform rating on Kura Oncology stock By Investing.com - Investing.com Canada
ETF Watch: Is AVDL vulnerable to short sellers2025 Top Decliners & High Accuracy Investment Entry Signals - baoquankhu1.vn
Treasury Yields: Whats the profit margin of Kura Oncology IncWeekly Trend Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Nan Fung Trinity HK Ltd. Invests $2.04 Million in Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology, Inc. (KURA) Growth Potential: Analyst Ratings Suggest A 295.93% Upside - DirectorsTalk Interviews
Kura Oncology Tightens Governance with Amended Bylaws - TipRanks
Don't Ignore The Insider Selling In Kura Oncology - simplywall.st
Insider Selling: Kura Oncology (NASDAQ:KURA) Insider Sells 6,414 Shares of Stock - MarketBeat
Why is Kura Oncology Inc. stock going upWeekly Risk Report & Low Drawdown Trading Techniques - mfd.ru
Kura Oncology CCO Powl sells $54,266 in stock By Investing.com - Investing.com South Africa
Kura oncology CSO Burrows sells $11k in shares By Investing.com - Investing.com Australia
Kura Oncology COO Ford sells $15,339 in stock By Investing.com - Investing.com UK
Kura Oncology’s chief legal officer sells $94,827 in stock By Investing.com - Investing.com UK
Kura Oncology’s chief legal officer sells $94,827 in stock - Investing.com
Kura Oncology (NASDAQ:KURA) Insider Mollie Leoni Sells 8,180 Shares - MarketBeat
Kathleen Ford Sells 1,813 Shares of Kura Oncology (NASDAQ:KURA) Stock - MarketBeat
Kura Oncology (NASDAQ:KURA) Insider Sells $11,091.06 in Stock - MarketBeat
Insider Selling: Kura Oncology (NASDAQ:KURA) SVP Sells 7,142 Shares of Stock - MarketBeat
Teresa Brophy Bair Sells 11,208 Shares of Kura Oncology (NASDAQ:KURA) Stock - MarketBeat
Kura Oncology’s chief medical officer, Leoni, sells $69k in stock By Investing.com - Investing.com South Africa
Kura Oncology SVP sells $60k in shares By Investing.com - Investing.com Nigeria
Kura Oncology’s chief medical officer, Leoni, sells $69k in stock - Investing.com UK
Kura oncology CSO Burrows sells $11k in shares - Investing.com
Kura Oncology SVP sells $60k in shares - Investing.com
Kura Oncology CCO Powl sells $54,266 in stock - Investing.com
Kura Oncology COO Ford sells $15,339 in stock - Investing.com
Understanding Momentum Shifts in (KURA) - Stock Traders Daily
Sector Gamma AS Takes $3.88 Million Position in Kura Oncology, Inc. $KURA - MarketBeat
Kura Oncology, Inc. (KURA) Rating Update: 258% Potential Upside Highlights Growth Potential In Biotech Sector - DirectorsTalk Interviews
Kura Oncology (NASDAQ:KURA) Cut to "Strong Sell" at Zacks Research - MarketBeat
Kura Oncology: Safety Profile Of Komzifti Supports My Upgrade To Strong Buy (NASDAQ:KURA) - Seeking Alpha
Jim Cramer calls Kura speculative but says "It's one of the stronger ones I've seen in a very long time" - MSN
Does Kura Oncology (NASDAQ:KURA) Have A Healthy Balance Sheet? - 富途资讯
Kura Oncology, Inc. (NASDAQ:KURA) Short Interest Up 37.5% in December - MarketBeat
Kura Oncology's finance SVP sells shares worth $38,958 - MSN
Finanzdaten der Kura Oncology Inc-Aktie (KURA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kura Oncology Inc-Aktie (KURA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FORD KATHLEEN | Chief Operating Officer |
Jan 27 '26 |
Sale |
8.46 |
1,813 |
15,339 |
153,560 |
| Leoni Mollie | Chief Medical Officer |
Jan 27 '26 |
Sale |
8.46 |
8,180 |
69,209 |
267,274 |
| DOYLE THOMAS JAMES | SVP, Finance & Accounting |
Jan 27 '26 |
Sale |
8.46 |
7,142 |
60,426 |
145,167 |
| Burrows Francis | Chief Scientific Officer |
Jan 27 '26 |
Sale |
8.46 |
1,311 |
11,092 |
32,424 |
| Bair Teresa Brophy | Chief Legal Officer |
Jan 27 '26 |
Sale |
8.46 |
11,208 |
94,828 |
226,931 |
1.12%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):